famotidine has been researched along with Enterocolitis, Pseudomembranous in 1 studies
Famotidine: A competitive histamine H2-receptor antagonist. Its main pharmacodynamic effect is the inhibition of gastric secretion.
Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pekova, L | 1 |
| Shomov, G | 1 |
| Mladenova, I | 1 |
| Pellicano, R | 1 |
1 other study available for famotidine and Enterocolitis, Pseudomembranous
| Article | Year |
|---|---|
Clostridium difficile-associated disease with lethal outcome in a 77-year-old woman. A case report.
Topics: Administration, Oral; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Ulcer Agents; Cholecy | 2007 |